María Fernanda López Fernández

Prevalence, Follow-Up and Clinical Significance of the Anticardiolipin Antibodies in Normal Subjects

Pilar Gándara Vila, Maria Carmen Garcia Hernandez, María Fernanda López Fernández et al. · Thrombosis and Haemostasis · 1994 · 281 citations

Heart Failure, Healthy Subjects, Immunology +21

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study

Adrian C. Newland, Bertrand Godeau, Victor Priego et al. · British Journal of Haematology · 2015 · 171 citations

Once-daily Subcutaneous Dalteparin, a Low Molecular Weight Heparin, for the Initial Treatment of Acute Deep Vein Thrombosis

Jean‐Noël Fiessinger, María Fernanda López Fernández, E. Gatterer et al. · Thrombosis and Haemostasis · 1996 · 138 citations

Thrombosis, Subcutaneous Injections, Venous Thrombosis +15

Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders

José María Bastida, Marı́a Luisa Lozano, Rocí­o Benito et al. · Haematologica · 2017 · 117 citations · Full text

Acquired von willebrand disease in multiple myeloma secondary to absorption of von willebrand factor by plasma cells

Carlos Richard, M A Cuadrado, Marta Prieto et al. · American Journal of Hematology · 1990 · 104 citations